Product image of Leuprol (Leuprorelin Acetate) supplied by GNH India

Leuprol

Active Ingredient:
Leuprorelin Acetate
Origin:
EU

Leuprol (Leuprorelin Acetate)

Leuprorelin acetate, the active ingredient in Leuprol, is a gonadotropin‑releasing hormone (GnRH) agonist presented as an injectable solution for intramuscular or subcutaneous administration. It is used to manage hormone‑dependent conditions such as prostate cancer, endometriosis, precocious puberty, uterine fibroids, and as adjuvant therapy in certain breast cancer treatments.

GNH India supplies Leuprol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, clinics and pharmacies worldwide, providing reliable access to this specialized hormone therapy through dedicated global robust quality systems.

Manufacturer / TM Owner

Pharmazac Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Leuprol, a GnRH agonist, is used to modulate hormone‑driven disease pathways.

  • Prostate cancer: lowers testosterone levels to slow tumor progression.
  • Endometriosis: suppresses estrogen production to reduce lesion growth and pain.
  • Precocious puberty: halts premature activation of the hypothalamic‑pituitary‑gonadal axis.
  • Uterine fibroids: diminishes estrogen‑driven fibroid enlargement.
  • Breast cancer (adjuvant): provides hormonal blockade to support other therapies.
  • Ovarian hyperstimulation syndrome: controls ovarian hormone surge during assisted reproduction.

How It Works

  • Leuprol contains leuprorelin acetate, a synthetic GnRH agonist that initially stimulates pituitary GnRH receptors, causing a transient rise in luteinizing hormone (LH) and follicle‑stimulating hormone (FSH). Continuous exposure leads to receptor down‑regulation, markedly reducing LH and FSH secretion and consequently decreasing downstream sex hormone production such as testosterone and estradiol.

Side Effects

Leuprol may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects

  • Hot flashes: sudden feeling of warmth and sweating.
  • Injection site reactions: pain, redness or swelling at the site.
  • Headache: mild to moderate intensity.
  • Mood changes: irritability or depressive symptoms.
  • Decreased libido: reduced sexual desire.
  • Menstrual irregularities: spotting or amenorrhea.

Serious or Rare Side Effects

  • Bone loss: increased risk of osteoporosis with long‑term use.
  • Cardiovascular events: rare cases of myocardial infarction or stroke.
  • Severe allergic reaction: anaphylaxis, angioedema or urticaria.
  • Pituitary apoplexy: sudden hemorrhage within the pituitary gland (extremely rare).

Precautions & Warnings

When prescribing Leuprol, several precautionary measures should be observed to ensure patient safety.

  • Baseline hormone assessment: evaluate LH, FSH and sex steroid levels before initiation.
  • Bone health monitoring: perform periodic densitometry for patients on long‑term therapy.
  • Cardiovascular risk evaluation: assess history of heart disease or thromboembolic events.
  • Liver function: use caution in patients with hepatic impairment.
  • Hypersensitivity: avoid in individuals with known allergy to leuprorelin or formulation components.
  • Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake the vial.

Avoid Interactions

Leuprol can interact with other medicines; awareness of these interactions helps to avoid complications.

Major Interactions (Avoid)

  • Concurrent GnRH antagonists or agonists: may cause excessive hormonal suppression.
  • Hormonal contraceptives: reduced efficacy, leading to unintended pregnancy.

Moderate Interactions (Monitor Closely)

  • Anticoagulants (e.g., warfarin): monitor INR as hormonal changes can affect clotting.
  • Glucocorticoids: increased risk of bone loss; consider calcium/vitamin D supplementation.
  • Antipsychotics that elevate prolactin: monitor for additive endocrine effects.

Frequently Asked Questions

Leuprol is a gonadotropin‑releasing hormone (GnRH) agonist indicated for hormone‑dependent conditions such as prostate cancer, endometriosis, precocious puberty, uterine fibroids, adjuvant breast cancer therapy, and management of ovarian hyperstimulation syndrome.

Leuprorelin acetate initially stimulates pituitary GnRH receptors, causing a brief rise in LH and FSH. Continued exposure down‑regulates these receptors, leading to sustained suppression of LH and FSH and consequently lowering sex hormone levels like testosterone and estradiol.

The appropriate dose of Leuprol is determined by the prescribing clinician based on the specific indication, patient weight, disease stage and treatment protocol. Dosage regimens are individualized and should follow the product’s prescribing information.

Leuprol’s safety in pregnancy and lactation has not been established. Because it suppresses sex hormone production, it is generally contraindicated in pregnant or nursing women unless the potential benefit outweighs the risk and a specialist advises otherwise.

To request Leuprol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed) and required import documentation.

Leuprol contains leuprorelin acetate, a well‑studied GnRH agonist with a similar efficacy profile to other agents such as goserelin or triptorelin. Differences may lie in dosing frequency, formulation stability and specific regulatory approvals, but the overall mechanism of hormonal suppression is comparable across the class.

Leuprol must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Keep the vial in its original packaging until use and discard any product that has been exposed to temperatures outside the recommended range.

Leuprol is supplied as an injectable solution for intramuscular or subcutaneous injection. Administration is performed by a qualified healthcare professional using aseptic technique, typically in a clinical setting, according to the dosing schedule prescribed by the treating physician.

Serious risks include significant bone loss leading to osteoporosis, rare cardiovascular events such as myocardial infarction or stroke, severe allergic reactions (anaphylaxis), and, in extremely rare cases, pituitary apoplexy. Patients should be monitored regularly for these complications.

Leuprol should not be used in individuals with known hypersensitivity to leuprorelin acetate or any excipients, in patients with uncontrolled cardiovascular disease, severe liver impairment, or in pregnant and nursing women unless clearly indicated by a specialist.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Leuprorelin Acetate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT